Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation. Wiebe J, Hofmann FJ, Dorr O, Bauer T, et al. Catheter Cardiovasc Interv 2021;97:56-62.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wiebe J, Hofmann FJ, Dorr O, Bauer T, et al. Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation. Catheter Cardiovasc Interv 2021;97:56-62.
PMID: 32187817